Literature DB >> 26832177

Twist Expression in Pleomorphic Adenoma, Adenoid Cystic Carcinoma and Mucoepidermoid Carcinoma of Salivary Glands.

Soheil Pardis1, Raziyeh Zare, Zohreh Jaafari-Ashkavandi, Mohammad Javad Ashraf, Bijan Khademi.   

Abstract

OBJECTIVE: Twist is an important transcription factor that induces epithelial-mesenchymal transition and therefore plays an important role in tumor progression. There are a few studies on Twist expression in salivary gland carcinomas. The aim of this study was to evaluate and compare the expression of Twist in the most common benign and malignant salivary gland tumors and to determine whether its expression was correlated with any tumor characteristics. MATERIAL AND
METHOD: In this retrospective cross-sectional study, 45 cases including 11 cases of normal salivary gland, 12 pleomorphic adenomas, 12 adenoid cystic carcinomas and 10 mucoepidermoid carcinomas were enrolled. The mean and intensity of Twist expression were evaluated immunohistochemically and were compared using statistical analysis.
RESULTS: The expression of Twist was higher in malignant salivary gland tumors in comparison with normal glands and benign tumors (p= 0.03). It was also higher in pleomorphic adenomas in comparison with normal tissue. Adenoid cystic carcinomas and mucoepidermoid carcinomas showed no significant difference in Twist expression (p= 0.50). There was no correlation with the size, stage or grade of tumor.
CONCLUSION: The findings showed that Twist might play a role in the formation of salivary gland neoplasm and also may affect malignant transformation and tumoral invasion. The exact mechanism of this marker and the possibility of using it as a therapeutic target require further investigation.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26832177     DOI: 10.5146/tjpath.2015.01343

Source DB:  PubMed          Journal:  Turk Patoloji Derg        ISSN: 1018-5615


  6 in total

1.  Cytoplasmic expression of Twist1, an EMT-related transcription factor, is associated with higher grades renal cell carcinomas and worse progression-free survival in clear cell renal cell carcinoma.

Authors:  Arezoo Rasti; Zahra Madjd; Maryam Abolhasani; Mitra Mehrazma; Leila Janani; Leili Saeednejad Zanjani; Mojgan Asgari
Journal:  Clin Exp Med       Date:  2017-12-04       Impact factor: 3.984

Review 2.  The role of the epithelial-to-mesenchymal transition (EMT) in diseases of the salivary glands.

Authors:  Margherita Sisto; Sabrina Lisi; Domenico Ribatti
Journal:  Histochem Cell Biol       Date:  2018-05-23       Impact factor: 4.304

3.  SLUG is a key regulator of epithelial-mesenchymal transition in pleomorphic adenoma.

Authors:  Hyesung Kim; Seung Bum Lee; Jae Kyung Myung; Jeong Hwan Park; Eunsun Park; Dong Il Kim; Cheol Lee; Younghoon Kim; Chul-Min Park; Min Bum Kim; Gil Chai Lim; Bogun Jang
Journal:  Lab Invest       Date:  2022-02-10       Impact factor: 5.662

4.  EMT in salivary gland tumors: the expression of microRNAs miR-155 and miR-200c is associated with clinical-pathological parameters.

Authors:  Leandra Ernst Kerche; Elen Alves de Sousa; Cristiane Helena Squarize; Katia Klug Oliveira; Fabio Albuquerque Marchi; Bárbara Beltrame Bettim; Luiz Paulo Kowalski; Fernando Augusto Soares; Silvia Vanessa Lourenço; Cláudia Malheiros Coutinho-Camillo
Journal:  Mol Biol Rep       Date:  2022-01-04       Impact factor: 2.316

5.  The immunophenotype of epithelial to mesenchymal transition inducing transcription factors in salivary gland adenoid cystic carcinomas.

Authors:  Iulia Cristiana Belulescu; Claudiu Mărgăritescu; Cristiana Iulia Dumitrescu; Maria Cristina Munteanu; Luminiţa Dăguci; Otilia Clara Mărgăritescu; Marius Matei
Journal:  Rom J Morphol Embryol       Date:  2020 Jul-Sep       Impact factor: 1.033

Review 6.  Pleomorphic Adenoma of the Salivary Glands and Epithelial-Mesenchymal Transition.

Authors:  Yuka Matsumiya-Matsumoto; Yoshihiro Morita; Narikazu Uzawa
Journal:  J Clin Med       Date:  2022-07-20       Impact factor: 4.964

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.